MRK - Company ID 0000310158
The table below shows Merck & Co., Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $65.01B | $64.17B | $60.12B | $59.28B | $48.70B | $41.52B |
| Cost of revenue | $16.38B | $15.19B | $16.13B | $17.41B | $13.63B | $13.62B |
| Gross profit | - | - | - | - | - | - |
| R&D | $15.79B | $17.94B | $30.53B | $13.55B | $12.24B | $13.40B |
Merck & Co., Inc. reported annual revenue of $65.01B for fiscal year 2025. That is up 1.3% from $64.17B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $39.81B (FY 2016) to $65.01B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $10.73B |
| $10.82B |
| $10.50B |
| $10.04B |
| $9.63B |
| $8.96B |
| Operating income | - | - | - | - | - | - |
| Income tax | $2.80B | $2.80B | $1.51B | $1.92B | $1.52B | $1.34B |
| Net income | $18.25B | $17.12B | $365.00M | $14.52B | $12.35B | $7.07B |
| EPS (diluted) | $7.28 | $6.74 | $0.14 | $5.71 | $5.14 | $2.78 |